FDA Announces Expansion of Total Product Life Cycle Advisory Program Pilot

Beginning October 1, 2023, the FDA’s Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot will expand to include the Office of Neurological and Physical Medicine Devices (OHT5).
The FDA’s Center for Devices and Radiological Health (CDRH) developed the voluntary Total Product…

Source: www.medtechintelligence.com – Read more